NeoGenomics, Inc. (NEO) vs Shoulder Innovations, Inc. (SI)
A side-by-side comparison of NeoGenomics, Inc. and Shoulder Innovations, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.
NEO
NeoGenomics, Inc.
$18.38HealthcareDelayed quote: Oct 2, 2026, 3:40 PM EDT
SI
Shoulder Innovations, Inc.
$19.17HealthcareDelayed quote: Oct 2, 2026, 3:39 PM EDT
Total return — NEO vs SI
growth of $100 · dividends reinvested · last 1yNEO +238.7% (+238.7%/yr)SI +24.6% (+24.6%/yr)NEO compounded faster over this window
NEO SI
NEO vs SI: by the numbers
- •NEO is the larger company ($472M vs $398M market cap).
- •Both run net losses; NEO's is the smaller (-6.77% vs -58.33% net margin).
Metrics side by side
Valuation
| Metric | NEO | SI |
|---|---|---|
| Forward P/E | 100.61 | N/A |
| P/S ratio | 0.62 | 6.62 |
| P/B ratio | 0.60 | 3.20 |
Profitability
| Metric | NEO | SI |
|---|---|---|
| Gross margin | 42.92% | 77.34% |
| Operating margin | -8.63% | -58.53% |
| Net margin | -6.77% | -58.33% |
| ROE | -6.60% | -28.18% |
| ROIC | -5.29% | -25.26% |
Growth (annualized)
| Metric | NEO | SI |
|---|---|---|
| Revenue CAGR (5Y) | 9.41% | N/A |
| Total return CAGR (5Y) | -18.18% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.